Articles of note for people dealing with pituitary disease and related conditions.
The latest from pharmaceutical companies and healthcare organizations
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Deep Fake or Deep Help? How AI Turned a Medical Paper into a Podcast (And Why That Matters)
An Opinion Editorial from Jorge D. Faccinetti – Co-founder and Chief Editor - In today's publishing landscape, one thing is clear: artificial intelligence and machine learning are advancing at dizzying speeds. Keeping up with these developments and understanding their true impact on our work and lives has become increasingly challenging.
Endo 2025 interviews; conversations with advocates, nurses, and specialty pharmacy executives
This week we bring you my chats from ENDO 2025 with Jill Sisco, president of the Acromegaly Community, Dr. Chris Yedinak, retired professor at Oregon Health and Science University, adjunct professor at Mount Marty University, and Alan Erck, Chief Commercial Officer at Anovo Pharmacy. Learn their outlook for patient care and support.
Worth noting:
Recordati announces FDA approval of ISTURISA® new indication in the U.S. to treat endogenous hypercortisolemia in patients with Cushing’s syndrome,- Learn more here
Corcept Therapeutics announces FDA Relacolirant new drug application to treat Hypercortisolism . Read more
From Crinetics Pharmaceuticals – FDA accepts Crinetics new drug Paltusotine’s application for adults with acromegaly . Read more
Camurus announces final results for the once-monthly octreotide subcutaneous treatment option for acromegaly. Read more
New support site from Chiesi; Rethink acromegaly
Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.
Chiesi relaunches a patient-facing website for Mycapssa.
Content for physicians and healthcare professionals.
Join a drug trial. Find out how. Here’s a partial list of studies.
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D. Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live Talk on Demand
This is a very informative discussion about the new indications of the Cushing's Drug Isturisa® (osilodrostat) with Dr. Mario Maldonado, who heads global development for endocrinology at Recordati Rare Diseases.
I recently had the pleasure of meeting Camurus CEO Fredrik Tiberg. We initially connected on a Zoom call and later met at the European Endocrine Conference held in Copenhagen, Denmark in May. We agreed to meet in person, learn more about the company and record a podcast.
Apple Podcasts
Spotify
Amazon Music
Google PodcastsEvents
Wednesday, September 17, 2025 – 7:30 PM Eastern Daylight Time
Click here for information and registration
